WallStreetZenWallStreetZen

NASDAQ: PRPH
Prophase Labs Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PRPH

Based on 1 analyst offering 12 month price targets for Prophase Labs Inc.
Min Forecast
$11.00+75.44%
Avg Forecast
$11.00+75.44%
Max Forecast
$11.00+75.44%

Should I buy or sell PRPH stock?

Based on 1 analyst offering ratings for Prophase Labs Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PRPH stock forecasts and price targets.

PRPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-21

1 of 1

Forecast return on equity

Is PRPH forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is PRPH forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PRPH revenue forecast

What is PRPH's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$52.6M+18.58%
Avg 2 year Forecast
$131.4M+195.99%
PRPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRPH revenue growth forecast

How is PRPH forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
29.85%
Industry
6.33%
Market
10.27%
PRPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRPH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
PRPH$6.27$11.00+75.44%Buy
FONR$16.52N/AN/A
BDSX$1.21$3.50+189.26%Strong Buy
STIM$3.96$8.00+102.02%Strong Buy
ACRS$1.23$5.00+306.50%Buy
View Top Diagnostic & Research Stocks

Prophase Labs Stock Forecast FAQ

Is Prophase Labs Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PRPH) stock is to Buy PRPH stock.

Out of 1 analyst, 0 (0%) are recommending PRPH as a Strong Buy, 1 (100%) are recommending PRPH as a Buy, 0 (0%) are recommending PRPH as a Hold, 0 (0%) are recommending PRPH as a Sell, and 0 (0%) are recommending PRPH as a Strong Sell.

If you're new to stock investing, here's how to buy Prophase Labs stock.

What is PRPH's revenue growth forecast for 2024-2025?

(NASDAQ: PRPH) Prophase Labs's forecast annual revenue growth rate of 29.85% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Prophase Labs's revenue in 2024 is $44,384,000.On average, 2 Wall Street analysts forecast PRPH's revenue for 2024 to be $949,719,350, with the lowest PRPH revenue forecast at $396,994,598, and the highest PRPH revenue forecast at $1,502,444,101.

In 2025, PRPH is forecast to generate $2,370,599,106 in revenue, with the lowest revenue forecast at $2,370,599,106 and the highest revenue forecast at $2,370,599,106.

What is PRPH's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PRPH) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of N/A.

What is PRPH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PRPH price target, the average PRPH price target is $11.00, with the highest PRPH stock price forecast at $11.00 and the lowest PRPH stock price forecast at $11.00.

The Wall Street analyst predicted that Prophase Labs's share price could reach $11.00 by Feb 21, 2025. The average Prophase Labs stock price prediction forecasts a potential upside of 75.44% from the current PRPH share price of $6.27.

What is PRPH's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PRPH) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.